BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 5166611)

  • 1. Significance of bivalence of antibody in viral neutralization.
    Rosenstein RW; Nisonoff A; Uhr JW
    J Exp Med; 1971 Dec; 134(6):1431-41. PubMed ID: 5166611
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neutralizing activities of early and late IgG fragments from rabbits immunized with herpes simplex virus.
    Shinkai K; Yoshino K
    Jpn J Microbiol; 1975 Jun; 19(3):211-8. PubMed ID: 170444
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neutralization of tetanus toxin by human and rabbit immunoglobulin classes and subunits.
    Ourth DD; MacDonald AB
    Immunology; 1977 Dec; 33(6):807-15. PubMed ID: 590997
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The mechanism of bacteriophage T4 neutralization: effects of univalent antibody fragments on T4 adsorption kinetics.
    Stemke GW; Knight WS; Butz E; Gates DJ
    Can J Microbiol; 1974 Apr; 20(4):499-508. PubMed ID: 4597643
    [No Abstract]   [Full Text] [Related]  

  • 5. Binding parameters and idiotypic profile of the whole immunoglobulin and Fab' fragments of murine monoclonal antibody to distinct determinants of the human high molecular weight-melanoma associated antigen.
    Temponi M; Gold AM; Ferrone S
    Cancer Res; 1992 May; 52(9):2497-503. PubMed ID: 1373670
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Naturally occurring antiglobulin factors in virus neutralization: homoreactant as a factor enhancing neutralization of the infectious complex of poliovirus with the Fab' antibody fragment.
    Kulberg AJ; Pervikov JV
    Infect Immun; 1976 Feb; 13(2):322-5. PubMed ID: 177361
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Kinetics of neutralization of bacteriophage f2 by rabbit gamma-G-antibodies.
    Dudley MA; Henkens RW; Rowlands DT
    Proc Natl Acad Sci U S A; 1970 Jan; 65(1):88-95. PubMed ID: 4905672
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Preparation and performance of bispecific F(ab' gamma)2 antibody containing thioether-linked Fab' gamma fragments.
    Glennie MJ; McBride HM; Worth AT; Stevenson GT
    J Immunol; 1987 Oct; 139(7):2367-75. PubMed ID: 2958547
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neutralization of T-even bacteriophage: the role of tail-sheath antigen in indirect neutralization.
    Stemke GW
    Can J Microbiol; 1974 May; 20(5):649-55. PubMed ID: 4598862
    [No Abstract]   [Full Text] [Related]  

  • 10. Biodistribution of monoclonal IgG1, F(ab')2, and Fab' in mice after intravenous injection. Comparison between anti-B cell (anti-Lyb8.2) and irrelevant (MOPC-21) antibodies.
    Holton OD; Black CD; Parker RJ; Covell DG; Barbet J; Sieber SM; Talley MJ; Weinstein JN
    J Immunol; 1987 Nov; 139(9):3041-9. PubMed ID: 3499463
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neutralizing F(ab')2 fragments of protective monoclonal antibodies to yellow fever virus (YF) envelope protein fail to protect mice against lethal YF encephalitis.
    Schlesinger JJ; Chapman S
    J Gen Virol; 1995 Jan; 76 ( Pt 1)():217-20. PubMed ID: 7844536
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The kinetics of antibody binding to membrane antigens in solution and at the cell surface.
    Mason DW; Williams AF
    Biochem J; 1980 Apr; 187(1):1-20. PubMed ID: 6967725
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Variations in the neutralizing and haemagglutination-inhibiting activities of five influenza A virus-specific IgGs and their antibody fragments.
    Schofield DJ; Stephenson JR; Dimmock NJ
    J Gen Virol; 1997 Oct; 78 ( Pt 10)():2431-9. PubMed ID: 9349461
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The role of antibody bivalence in the neutralization of bacteriophage.
    Klinman NR; Long CA; Karush F
    J Immunol; 1967 Dec; 99(6):1128-33. PubMed ID: 4168661
    [No Abstract]   [Full Text] [Related]  

  • 15. Idiotypic determinants on human T cells and modulation of human T cell responses by anti-idiotypic antibodies.
    Geha RS
    J Immunol; 1984 Oct; 133(4):1846-51. PubMed ID: 6206140
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Further evidence for cross-linking as a protective factor in experimental cholera: properties of antibody fragments.
    Steele EJ; Chaicumpa W; Rowley D
    J Infect Dis; 1975 Aug; 132(2):175-80. PubMed ID: 1159322
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antiidiotypic activity in the IgM fractions of mixed cryoglobulins.
    Geltner D; Franklin EC; Frangione B
    J Immunol; 1980 Oct; 125(4):1530-5. PubMed ID: 6774023
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Production and characterization of anti-human IgG F(ab')2 antibody fragment.
    Valedkarimi Z; Nasiri H; Aghebati-Maleki L; Abdolalizadeh J; Esparvarinha M; Majidi J
    Hum Antibodies; 2018; 26(4):171-176. PubMed ID: 29689714
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interpretation of results from the competitive Biacore procedure for characterizing immunochemical interactions in solution.
    Winzor DJ
    J Mol Recognit; 2018 Jul; 31(7):e2702. PubMed ID: 29484741
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Targeting of liver metastases of colorectal cancer with IgG, F(ab')2, and Fab' anti-carcinoembryonic antigen antibodies labeled with 99mTc: the role of metabolism and kinetics.
    Behr T; Becker W; Hannappel E; Goldenberg DM; Wolf F
    Cancer Res; 1995 Dec; 55(23 Suppl):5777s-5785s. PubMed ID: 7493346
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.